New DTaP vaccine safety trial for children
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be in one of these age groups: 6 years old, 18-24 months old, or 2-3 months old.
- For 6-year-olds: must have already received 4 doses of the DTaP vaccine and not yet gotten the Td (tetanus-diphtheria) booster.
- For toddlers (18-24 months): must have received 3 doses of DTaP and 3 doses of polio vaccine, and not yet their booster doses.
- For infants (2-3 months): must never have received any DTaP, polio, or certain other vaccines (like Prevnar or Hib).
- Your child must be healthy, with no fever, no serious allergies to vaccines, and no history of seizures or brain disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a lower-dose vaccine that protects against diphtheria, tetanus, and whooping cough. It aims to see if the vaccine is safe and how well it works for people aged 6 and older, possibly offering a booster with fewer side effects.
This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.
This study checks if the protection from an earlier vaccine (against whooping cough, diphtheria, and tetanus) lasts over time. Participants from a previous study will give blood samples to measure their immune response.
This study tests a new type of whooping cough vaccine given to pregnant women to see if it helps protect their babies from whooping cough in the first months of life. The vaccine is given during pregnancy, and then the baby's immune response is checked up to 15–18 months old.
This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
Hear when a new Diphtheria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.